Sully, Mike, and Mary interview Dr. Uttam Patil of ABVC BioPharma and discuss their lead programs including ABV-1504 for major depressive disorder and ABV-1505 for attention-deficit/hyperactivity disorder.
February 7, 2023
Sully, Mike, and Mary interview Dr. Uttam Patil of ABVC BioPharma and discuss their lead programs including ABV-1504 for major depressive disorder and ABV-1505 for attention-deficit/hyperactivity disorder.
Other Interviews
